COMMUNIQUÉS West-GlobeNewswire

ProLynx annonce la publication et le début du recrutement des patients pour l'essai d'un traitement mensuel du diabète chez le chat
05/09/2019
SAN FRANCISCO, 05 sept. 2019 (GLOBE NEWSWIRE) -- Aujourd'hui, ProLynx a annoncé la publication de données détaillées sur le traitement du diabète de type 2 chez le chat avec le PLX039, un agoniste du récepteur du GLP-1 [...]
Pixium Vision to Participate in Multiple Upcoming Industry Events
05/09/2019
Pixium Vision to Participate in Multiple Upcoming Industry Events Paris, 5 September 2019 – 5:45 PM CEST - Pixium Vision (FR0011950641 - PIX), a bioelectronics company developing innovative bionic vision systems to [...]
Pixium Vision annonce sa participation à plusieurs évènements à venir
05/09/2019
Pixium Vision annonce sa participation à plusieurs évènements à venir Paris, 5 septembre 2019 – 17:45 CEST - Pixium Vision (FR0011950641 - PIX), société bioélectronique qui développe des systèmes de vision bionique [...]
Oxurion NV Business Update – H1 2019
05/09/2019
Positive Topline Phase 1 Results with THR-149 (Plasma Kallikrein Inhibitor) for treatment of DME Mixed Topline Results from exploratory THR-317 (anti-PlGF) Phase 2a ranibizumab combination study for the treatment of DME [...]
WeedMD Announces Upsize of its Previously Announced Bought-Deal Offering of Convertible Debenture Units to $12 Million
05/09/2019
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, Sept. 05, 2019 (GLOBE NEWSWIRE) -- WeedMD Inc. ( TSX-V:WMD ) (OTCQX:WDDMF) (FSE:4WE) (“ WeedMD ” or the “ Company ”), a [...]
Cabaletta Bio Expands Management Team with Appointment of Brian Stalter as General Counsel
05/09/2019
Mr. Stalter joins Cabaletta with more than 20 years of general corporate and deal-making experience in small biotech and large pharma organizations PHILADELPHIA, Sept. 05, 2019 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc., a [...]
Generex Announces Webcast
05/09/2019
CEO Joe Moscato’s Presentation at the H.C. Wainwright 21 st ANNUAL GLOBAL INVESTMENT CONFERENCE to be Webcast by Wall Street Webcasting Monday September 9, 2019 3:25 PM MIRAMAR, Fla., Sept. 05, 2019 (GLOBE NEWSWIRE) -- [...]
BioRestorative Therapies’ Stockholders Approve Institutional Investor Agreement and Exchange Agreements
05/09/2019
MELVILLE, N.Y., Sept. 05, 2019 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (the “Company") (OTC: BRTX), a life sciences company focused on stem cell-based therapies, today announced that, at a special meeting of [...]
Precipio and University of Pennsylvania Enter into Joint Collaboration Agreement for Pathology Diagnostics
05/09/2019
First cases already diagnosed and reported by Penn expert pathologists NEW HAVEN, Conn., Sept. 05, 2019 (GLOBE NEWSWIRE) -- Specialty Diagnostics company Precipio, Inc . ( NASDAQ: PRPO ), announced today a major [...]
BridgeBio Pharma expands its research into neuromuscular disease to include Limb-Girdle Muscular Dystrophy Type 2 (LGMD2i) with new subsidiary ML Bio Solutions
05/09/2019
Provides BridgeBio with leading scientific expertise to develop oral small molecule therapy for LGMD2i CHARLOTTE, N.C. and SAN FRANCISCO, Sept. 05, 2019 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (NASDAQ: BBIO) today [...]
Oasmia publishes its annual report and adjusts accounts due to write-downs - auditors do not recommend former board to be granted discharge from liability
05/09/2019
Oasmia Pharmaceutical AB's annual report for the fiscal year 2018/2019 is now available on the company's website www.oasmia.com . Compared to the year-end report, which was published on June 28, the financial statements [...]
Media Advisory: JDRF Brings Together Pickering Community, Researcher, and Elected Officials to Discuss Affordable Access to Life-Changing Technologies for type 1 diabetes
05/09/2019
PICKERING, Ontario, Sept. 05, 2019 (GLOBE NEWSWIRE) -- On Thursday, September 12, JDRF Canada will host a community forum to address the need for access to affordable type 1 diabetes (T1D) technologies for the more than [...]
ProLynx announces publication and initiation of patient recruitment for a trial of once-monthly treatment of diabetes in cats
05/09/2019
SAN FRANCISCO, Sept. 05, 2019 (GLOBE NEWSWIRE) -- Today, ProLynx announced publication of data supporting therapy of Type 2 diabetes in cats with PLX039, a GLP-1 receptor agonist that can be administered once every [...]
La Jolla Pharmaceutical Company to Present at the 21st Annual H.C. Wainwright Global Investment Conference
05/09/2019
SAN DIEGO, Sept. 05, 2019 (GLOBE NEWSWIRE) -- La Jolla Pharmaceutical Company (Nasdaq: LJPC), a leader in the discovery, development and commercialization of innovative therapies intended to significantly improve [...]
athenahealth Welcomes Paul Brient as Chief Product Officer
05/09/2019
Former PatientKeeper CEO and Industry Innovator to Drive Product Strategy for Healthcare IT Pioneer WATERTOWN, Mass., Sept. 05, 2019 (GLOBE NEWSWIRE) -- athenahealth, Inc., a leading provider of network-enabled services [...]
HearAtLast Holdings Acquires 100% of Fast Growing Canadian Start-up Crystal Clear Audio
05/09/2019
LAS VEGAS, NV, Sept. 05, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- HearAtLast Holdings, Inc. (OTC:HRAL) , a holding company currently involved in restructuring and expanding its business model, revenue and asset base [...]
AMAG Pharmaceuticals to Present at Morgan Stanley Global Healthcare Conference
05/09/2019
WALTHAM, Mass., Sept. 05, 2019 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) will participate in the Morgan Stanley Global Healthcare Conference on Tuesday, September 10, 2019. Bill Heiden, president and [...]
Forward Pharma to Participate in the Fall Investor Summit in New York
05/09/2019
COPENHAGEN, Denmark, Sept. 05, 2019 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (the “Company”) today announced that Chief Executive Officer, Dr. Claus Bo Svendsen, will participate in the Fall Investor Summit [...]
Tula Health Closes $2.6 Million Seed Round to Develop Personalized Digital Health Platform
05/09/2019
KAYSVILLE, Utah, Sept. 05, 2019 (GLOBE NEWSWIRE) -- Tula Health, Inc, a transformative personalized digital health platform that continuously and noninvasively monitors blood glucose and key health metrics through its [...]

Pages